Discontinuation report METRONIDAZOLE INJECTION USP
Report ID | 79639 |
Drug Identification Number | 00649074 |
Brand name | METRONIDAZOLE INJECTION USP |
Common or Proper name | Metronidazole Injection USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | METRONIDAZOLE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 80 x 100mL PLBG |
ATC code | J01XD |
ATC description | OTHER ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-07-02 |
Remaining supply date | 2020-07-02 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | METRONIDAZOLE 5mg/mL 24x100mL PLBG remains available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-07-03 | French | Compare |
v5 | 2019-07-03 | English | Compare |
v4 | 2019-06-04 | French | Compare |
v3 | 2019-06-04 | English | Compare |
v2 | 2019-03-27 | French | Compare |
v1 | 2019-03-27 | English | Compare |
Showing 1 to 6 of 6